Detection of carbapenemases in acinetobacter baumannii and analysis of epidemiology

CHEN Zhen-hua,GAO Qian,ZOU Ming-xiang,DENG Hong-li,LI Yan-bing,YE Chun-mei

2011-01-01

Abstract:OBJECTIVE To investigate the drug resistance and carbapenemases seatus in clinical isolates of Acinetobacter baumannii,study molecular epidemiology and resistance mechanism of carbapenemase-producing isolates.METHODS Totally 179 clinical isolates of A.baumannii were collected from Jan to Jun 2009 in hospital.Antimicrobial susceptibility test was performed by disk diffusion method.Modified Hodge test was used to screen the strains producing carbapenemases.Carbapenemase genes were amplified using PCR and sequenced.Plasmid conjugation experiments were done to study,the transfer of carbapenemase genes and the homology of these isolates were analyzed by typing of ERIC-PCR in order to explain the molecular mechanism of drug resistance and epidemiology characteristics.RESULTS In all 179 isolates,the drug resistant rates to imipenem,meropenem,ampicillin-sulbactam,cefoperazone-sulbactam,and minocycline were 49.2%,48.0%,45.3%,6.7% and 7.8% respectively,the resistant rates to all other tested antimicrobial agents were more than 50.0%.74 of 179 strains were positive in modified Hodge test.OXA-23 gene was found in 71 strains.Carbapenemase genes were unable to transfer via plasmid,74 strains were divided into 4 genotypes by ERIC-PCR and they had spread widely in many wards.CONCLUSION The resistance of A.baumannii is serious,and many of them produce carbapenemase.OXA-23 gene is the popular carbapenemase genotype.The spread of carbapenemase-producing isolates clone results in the high rate of carbapenem resistance.